Dermata Therapeutics Inc (DRMA): Insights At A Glance
Acadian Asset Management LLC has recently announced that it has increased stake in Dermata Therapeutics Inc (NASDAQ:DRMA) by 34.21%. After grabbing 75538.0 shares, the institutional investor is now in possession of 19253.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.37% having worth around $56276.0. Moreover, Geode Capital […]
